In this paper, we developed an experimentally validated mathematical model for the dynamics of advanced bladder cancer growth and response to receptor tyrosine kinase (RTK) targeted therapy alone and in combination with an ICI. The gene discussed is NTRK1; the disease is urinary bladder cancer.